Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor J L, de Gaetano G, Cerletti C
G. Bizzozero Laboratory of Platelet and Leukocyte Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.
Blood. 1996 Dec 1;88(11):4183-94.
Adhesion between platelets and polymorphonuclear leukocytes (PMN) is a key event in thrombosis and inflammation. Double color fluorescence-activated cell sorter (FACS) analysis was used to determine the extent and kinetics of adhesion of thrombin-activated platelets to resting or activated PMN when mixed cell populations were incubated in dynamic conditions. Activated platelets bound very rapidly to PMN. Mixed cell conjugates reached a maximum at 1 minute and were reversible within 10 minutes. Platelet/PMN adhesion required both Ca2+ and Mg2+ and was markedly increased by the presence of Mn2+. The latter made mixed cell conjugates stable up to 10 minutes. Adhesion of platelets required metabolic activity of PMN and was abolished by tyrosine kinase inhibitors. Furthermore, adhesion of platelets to PMN resulted in binding of a monoclonal antibody (MoAb 24) known as beta 2 integrins "activation reporter." When PMN were activated by exogenous stimuli, the adhesion of platelets was markedly increased: fMLP induced a rapid and transient effect, while PMA resulted in a slower, but stable, increase in mixed conjugates formation. The hypothesis that activated PMN beta 2 integrins are able to bind a counter-receptor on platelets was directly demonstrated by the increase of mixed cell conjugates following PMN treatment with KIM127 and KIM185, two anti-CD18 antibodies able to induce the active conformation of beta 2 integrins. Consistently, two other anti-CD18, as well as an anti-CD11b inhibitory antibody abolished platelet/PMN adhesion. PMN beta 2 integrin activation was not the only mechanism for activated platelet/PMN adhesion to occur: indeed, this phenomenon could also be inhibited by two anti-P-selectin antibodies. Resting platelets did not adhere to resting PMN, but markedly adhered to fMLP- or PMA-activated PMN. Resting platelet/fMLP-activated PMN adhesion was abolished by anti-CD18 antibodies, but not by anti-P-selectin antibodies. In conclusion, activated platelet/PMN interaction can be modeled as an adhesion cascade involving a P-selectin-dependent recognition step and a functional signal. The latter proceeds through tyrosine kinase activation and enables a beta 2 integrin-dependent adhesion to a not yet identified counter-receptor constitutively expressed on platelet surface.
血小板与多形核白细胞(PMN)之间的黏附是血栓形成和炎症过程中的关键事件。当混合细胞群体在动态条件下孵育时,采用双色荧光激活细胞分选仪(FACS)分析来确定凝血酶激活的血小板与静息或激活的PMN黏附的程度和动力学。激活的血小板与PMN的结合非常迅速。混合细胞结合物在1分钟时达到最大值,并在10分钟内可逆。血小板/PMN黏附需要Ca2+和Mg2+,并且Mn2+的存在会显著增加黏附。后者使混合细胞结合物在长达10分钟内保持稳定。血小板的黏附需要PMN的代谢活性,并且酪氨酸激酶抑制剂可消除这种黏附。此外,血小板与PMN的黏附导致一种称为β2整合素“激活报告分子”的单克隆抗体(MoAb 24)的结合。当PMN被外源性刺激激活时,血小板的黏附显著增加:fMLP诱导快速且短暂的效应,而PMA导致混合结合物形成的增加较慢但稳定。用KIM127和KIM185(两种能够诱导β2整合素活性构象的抗CD18抗体)处理PMN后,混合细胞结合物增加,直接证明了激活的PMNβ2整合素能够与血小板上的反受体结合这一假设。一致地,另外两种抗CD18抗体以及一种抗CD11b抑制性抗体消除了血小板/PMN黏附。PMNβ2整合素激活不是激活的血小板/PMN黏附发生的唯一机制:实际上,这种现象也可被两种抗P-选择素抗体抑制。静息血小板不与静息PMN黏附,但显著黏附于fMLP或PMA激活的PMN。抗CD18抗体可消除静息血小板/fMLP激活的PMN黏附,但抗P-选择素抗体不能。总之,激活的血小板/PMN相互作用可被模拟为一个黏附级联反应,涉及一个P-选择素依赖性识别步骤和一个功能性信号。后者通过酪氨酸激酶激活进行,并使依赖β2整合素的黏附作用于血小板表面组成性表达的尚未确定的反受体。